Drug Shortage Report for GLYCOPYRROLATE INJECTION USP
Report ID | 167366 |
Drug Identification Number | 02039508 |
Brand name | GLYCOPYRROLATE INJECTION USP |
Common or Proper name | GLYCOPYRROLATE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | GLYCOPYRROLATE |
Strength(s) | 0.2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 2ML 10LIVI |
ATC code | A03AB |
ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-09-01 |
Estimated end date | 2022-11-18 |
Actual end date | 2022-11-28 |
Shortage status | Resolved |
Updated date | 2022-11-29 |
Company comments | Product is available on allocation at wholesalers, based on 100% of historical volumes. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2022-11-29 | English | Compare |
v14 | 2022-11-28 | French | Compare |
v13 | 2022-11-28 | English | Compare |
v12 | 2022-11-28 | French | Compare |
v11 | 2022-11-28 | English | Compare |
v10 | 2022-10-19 | French | Compare |
v9 | 2022-10-19 | English | Compare |
v8 | 2022-09-21 | French | Compare |
v7 | 2022-09-21 | English | Compare |
v6 | 2022-09-02 | English | Compare |
v5 | 2022-09-01 | French | Compare |
v4 | 2022-09-01 | English | Compare |
v3 | 2022-08-23 | English | Compare |
v2 | 2022-08-19 | French | Compare |
v1 | 2022-08-19 | English | Compare |
Showing 1 to 15 of 15